Literature DB >> 8717638

Opioid receptors and the regulation of ion conductances.

T J Grudt1, J T Williams.   

Abstract

In the past two years, knowledge about the regulation of ion conductances by opioid receptors has expanded in several directions. First, it has now been shown that all three of the major receptor subtypes act on all three of the well recognized effectors, i.e., adenylyl cyclase, calcium channels and potassium channels. Second, the opioid-mediated receptor inhibition of adenylyl cyclase has been linked to the modulation of ion channel activity /20/. Third, opioids have also been found to increase the activity of adenylyl cyclase in some preparations. Fourth, opioid receptors can mediate a rise in internal free-calcium concentration /21/. These observations suggest that the regulation of cell excitability by opioids is dependent on the cell under study and that the generalization between receptor subtype and specificity of action is no longer valid. The additional second messenger pathways affected by opioids suggest that the adaptive changes resulting from chronic opioid treatment are more complex than previously thought. This review evaluates these relatively new observations and suggests how these results may change the interpretations from previous work on opioid actions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8717638     DOI: 10.1515/revneuro.1995.6.3.279

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  12 in total

1.  Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.

Authors:  Sonia I Ortiz-Miranda; Govindan Dayanithi; Cristina Velázquez-Marrero; Edward E Custer; Steven N Treistman; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  κ-Opioid Receptor Modulation of GABAergic Inputs onto Ventrolateral Periaqueductal Gray Dopamine Neurons.

Authors:  Chia Li; Thomas L Kash
Journal:  Mol Neuropsychiatry       Date:  2019-05-17

3.  Morphine-activated opioid receptors elude desensitization by beta-arrestin.

Authors:  J L Whistler; M von Zastrow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

4.  Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area.

Authors:  A Bonci; R C Malenka
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

5.  cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats.

Authors:  K Ballanyi; P M Lalley; B Hoch; D W Richter
Journal:  J Physiol       Date:  1997-10-01       Impact factor: 5.182

Review 6.  Kinase cascades and ligand-directed signaling at the kappa opioid receptor.

Authors:  Michael R Bruchas; Charles Chavkin
Journal:  Psychopharmacology (Berl)       Date:  2010-04-17       Impact factor: 4.530

7.  Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.

Authors:  Fang Zheng; David K Grandy; Steven W Johnson
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

9.  Regulator of G-Protein Signaling 7 Regulates Reward Behavior by Controlling Opioid Signaling in the Striatum.

Authors:  Laurie P Sutton; Olga Ostrovskaya; Maria Dao; Keqiang Xie; Cesare Orlandi; Roy Smith; Sunmee Wee; Kirill A Martemyanov
Journal:  Biol Psychiatry       Date:  2015-08-14       Impact factor: 13.382

Review 10.  Opioidergic and dopaminergic modulation of respiration.

Authors:  Peter M Lalley
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.